Skip to content

Data Migration and Mapping Functions

Data Migration and Mapping Functions

Medical software does not have a good reputation for user experience and intuitive design. It can seem like a full-time job just learning how to use these software solutions.  In fact, according to a study from Stanford Medicine, 74% of doctors responded that their EMR increased the number of hours they work every day and 71% say their EMRs lead to physician burnout.  With this information, coupled with the increase use of telehealth (another software to learn), it’s no wonder that providers and their staff are looking for alternatives to simplify their clinical software, while not sacrificing the quality of patient care.

At Arfinn Med, we believe that your clinical software should be easy to use, fast and allow you to spend more time focusing on patient care rather than data entry. This focus on intuitive software design is why we are the leading EMR for alternative medicine clinics including practices focusing on cannabis and cannabinoid medicine.  Despite this, we still hear from providers who wish to switch to our platform that they are concerned about migrating data from paper charts or from another system.  We at Arfinn Med decided to address this concern.

We are proud to release our new secure data mapping software and a team of employees to focus on data migration.  This new system will allow us to speed up the time it takes to switch patient data, while also not interrupting your current practice workflows. You will also be assigned a team member from Arfinn to help with extraction of any additional data such as attached files, appointments and/or consents.

If you are interested in learning more about our data migration protocol, please reach out to us at info@arfinnmed.com.

Sincerely from quarantine,

The Arfinn Med Team

Stories you may be interested in

Military Times: “Our veterans deserve the well-being that medical cannabis can provide.”

The physical and mental trauma that veterans experience as a result of their military service extends far beyond the end of their participation in combat-related roles. To recognize the sacrifices veterans have made to protect our country, state and federal lawmakers must continue to expand access to crucial treatment options and programs that assist veterans…
Read More

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new…
Read More

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated…
Read More

IBD and Cannabinoid Medicine

With an estimated 3.1 million adults diagnosed with Irritable Bowel Disease (IBD) in the United States, it’s natural that many people are asking about the possible benefits of cannabis for the symptoms associated with IBD. In fact, the University of Michigan Health Department received so many questions regarding this issue, that they released a Q&A…
Read More

Leave a Comment

You must be logged in to post a comment.